Department of Vascular Surgery, The Second Xiangya Hospital of Central South University, Changsha, 410011, Hunan, China.
Vascular Diseases Institute of Central South University, Changsha, Hunan, China.
J Cardiothorac Surg. 2023 Oct 25;18(1):299. doi: 10.1186/s13019-023-02345-8.
Thoracic aortic pseudoaneurysm (TAP) is an uncommon but life-threatening condition. The present study aimed to investigate the early and midterm clinical outcome of TAP patients following TEVAR and identify potential mortality predictors.
We retrospectively reviewed a series of 37 eligible patients with TAP admitted to our hospital from July 2010 to July 2020. We explored their baseline, perioperative and follow-up data. Fisher exact test and Kaplan-Meier method were applied for comparing difference between groups.
There were 29 men and 12 women, with the mean age as 59.5 ± 13.0 years (range 30-82). The mean follow-up period was 30.7 ± 28.3 months (range 1-89). For early outcome (≤ 30 days), mortality happened in 3 (8.1%) zone 3 TAP patients versus 0 in zone 4 (p = 0.028); postoperative acute arterial embolism of lower extremity and type II endoleak respectively occurred in 1(2.7%) case. For midterm outcome, survival at 3 months, 1 year and 5 years was 88.8%, 75.9% and 68.3%, which showed significant difference between zone 2/3 versus zone 4 group (56.3% vs. 72.9%, p = 0.013) and emergent versus elective TEVAR group (0.0% versus 80.1%, p = 0.049). Previous stent grafting or esophageal foreign body with Aortoesophageal fistula (AEF), and systemic vasculitis, as etiologies, resulted in encouraging immediate outcome but worse midterm prognosis.
TAP lesions at zone 2/3 and emergent TEVAR predict worse midterm outcomes compared to zone 4 lesions and elective TEVAR. The outcomes are also mainly restricted by the etiology of the TAP.
胸主动脉假性动脉瘤(TAP)是一种罕见但危及生命的疾病。本研究旨在探讨 TAP 患者接受 TEVAR 治疗后的早期和中期临床结果,并确定潜在的死亡率预测因素。
我们回顾性分析了 2010 年 7 月至 2020 年 7 月期间我院收治的 37 例 TAP 患者的基线、围手术期和随访资料。我们探讨了他们的基线、围手术期和随访数据。应用 Fisher 确切检验和 Kaplan-Meier 方法比较组间差异。
男性 29 例,女性 12 例,平均年龄 59.5±13.0 岁(范围 30-82 岁)。平均随访时间为 30.7±28.3 个月(范围 1-89 个月)。对于早期结果(≤30 天),3 例(8.1%)Zone 3 TAP 患者死亡,而 Zone 4 患者无死亡(p=0.028);分别有 1 例(2.7%)患者术后发生下肢急性动脉栓塞和 II 型内漏。对于中期结果,3 个月、1 年和 5 年生存率分别为 88.8%、75.9%和 68.3%,Zone 2/3 与 Zone 4 组之间有显著差异(56.3% vs. 72.9%,p=0.013),急诊与择期 TEVAR 组之间也有显著差异(0.0% vs. 80.1%,p=0.049)。以前的支架移植或食管异物伴主动脉食管瘘(AEF)和系统性血管炎作为病因,导致即刻结果令人鼓舞,但中期预后较差。
与 Zone 4 病变和择期 TEVAR 相比,Zone 2/3 的 TAP 病变和急诊 TEVAR 预测中期预后更差。结果主要受 TAP 病因的限制。